Markets:

Overview

News

Currencies

International

Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

2.170 -0.060 (-2.69%)

Streaming Delayed Price Updated: 11:51 AM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

2 Small-Cap Stocks with Competitive Advantages and 1 That Underwhelm

March 13, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

March 11, 2026

From GoodRx

Via Business Wire

Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know

March 06, 2026

Via StockStory

Topics Economy

GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®

March 06, 2026

From GoodRx

Via Business Wire

GoodRx Holdings Inc (NASDAQ:GDRX) Stock Falls on Cautious 2026 Revenue Outlook ↗

February 25, 2026

Via Chartmill

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

February 27, 2026

A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key...

Via StockStory

Topics Economy Government Stocks

GoodRx (GDRX) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

GoodRx (GDRX) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Bankruptcy Earnings

GoodRx’s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8%

February 25, 2026

Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.9% year on year to $194.8 million. On the other hand, the...

Via StockStory

Top movers in Wednesday's after hours session ↗

February 25, 2026

Via Chartmill

GoodRx Reports Fourth Quarter and Full Year 2025 Results

February 25, 2026

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”

February 24, 2026

From GoodRx

Via Business Wire

GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

February 23, 2026

Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results this Wednesday after the bell. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Government World Trade

GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?

February 17, 2026

GoodRx’s stock price has taken a beating over the past six months, shedding 56.5% of its value and falling to $2.23 per share. This was partly due to its softer quarterly results and may have investors...

Via StockStory

Topics Supply Chain

1 Healthcare Stock with Promising Prospects and 2 Facing Challenges

February 10, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

Via StockStory

Topics Stocks

Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. ↗

February 05, 2026

There's another fight brewing around GLP-1 drugs -- this time on the delivery side.

Via The Motley Fool

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

February 05, 2026

From GoodRx

Via Business Wire

1 Oversold Stock Set for a Comeback and 2 We Brush Off

February 04, 2026

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

February 02, 2026

From GoodRx

Via Business Wire

1 Stock Under $10 to Target This Week and 2 Facing Headwinds

February 01, 2026

Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack...

Via StockStory

1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question

January 29, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

January 28, 2026

From GoodRx Holdings, Inc.

Via Business Wire

Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

January 25, 2026

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx (NASDAQ:GDRX) and its peers.

Via StockStory

Surescripts and GoodRx Partner to Advance Patient Price Transparency

January 13, 2026

From Surescripts

Via Business Wire

GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

January 08, 2026

From GoodRx

Via Business Wire

Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗

January 05, 2026

The development comes as attention remains on Hims’ longer-term business expansion initiatives.

Via Stocktwits

GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

January 05, 2026

From GoodRx

Via Business Wire

1 Cash-Producing Stock to Keep an Eye On and 2 We Avoid

December 31, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

1 Value Stock to Target This Week and 2 Facing Headwinds

December 28, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

3 Healthcare Stocks We Approach with Caution

December 18, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

Via StockStory

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.